Showing results (291-300 of 424) with videos related to
Sort By:
Pageof 43
BMC Gastroenterology|March 29, 2012
Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkersJohannes Vermehren, Annika Vermehren, Axel Mueller, et al.International Journal of Antimicrobial Agents|September 22, 2018
Net emergence of substitutions at position 28 in NS5A of hepatitis C virus genotype 4 in patients failing direct-acting antivirals detected by next-generation sequencingThuy Nguyen, Sepideh Akhavan, Fabienne Caby, et al.Alimentary Pharmacology & Therapeutics|October 3, 2023
Design of the phase 3 MAESTRO clinical program to evaluate resmetirom for the treatment of nonalcoholic steatohepatitisStephen A Harrison, Vlad Ratziu, Quentin M Anstee, et al.JHEP Reports : Innovation in Hepatology|February 11, 2020
Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver diseaseMarie Boyle, Dina Tiniakos, Jorn M Schattenberg, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 31, 2013
Non-invasive measurement of liver and pancreas fibrosis in patients with cystic fibrosisMireen Friedrich-Rust, Nina Schlueter, Christina Smaczny, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 2, 2018
Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus-Associated Cryoglobulinemia VasculitisPatrice Cacoub, Si Nafa Si Ahmed, Yasmina Ferfar, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|August 1, 2020
Transportation and handling of blood samples prior to ammonia measurement in the real life of a large university hospitalFrançoise Imbert-Bismut, Pierre-Emeric Payet, Jamal Alfaisal, et al.The New England Journal of Medicine|June 7, 2024
A Phase 2 Randomized Trial of Survodutide in MASH and FibrosisArun J Sanyal, Pierre Bedossa, Mandy Fraessdorf, et al.Journal of the American College of Cardiology|February 4, 2026
MASLD, MASH, and the CKM Spectrum: A Roadmap for Multiorgan Clinical Trial DesignFaiez Zannad, Muhammad Shahzeb Khan, Nisha Bansal, et al.International Journal of Molecular Sciences|August 12, 2023
Adlercreutzia equolifaciens Is an Anti-Inflammatory Commensal Bacterium with Decreased Abundance in Gut Microbiota of Patients with Metabolic Liver DiseaseFlorian Plaza Oñate, Célia Chamignon, Sebastian D Burz, et al.Pageof 43